Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 8 (August)

1. Search strategies for retrieving complementary and alternative medicine clinical trials in oncology.
   Integr Cancer Ther, 5(3): 202-5. [Abstract] [Full-text]
2. Partnerships in oncology and radiology: the role of radiology in the detection, staging, and follow-up of lung cancer.
   Oncologist, 11(7): 774-9. [Abstract] [Full-text]
3. Herb-drug interactions in oncology: focus on mechanisms of induction.
   Oncologist, 11(7): 742-52. [Abstract] [Full-text]
4. Attitudes to spiritual care among nursing staff in a Swedish oncology clinic.
   J Clin Nurs, 15(7): 863-74. [Abstract] [Full-text]
5. Confidence intervals and survival estimates: a systematic review of 3 oncology journals.
   Am J Clin Oncol, 29(4): 405-7. [Abstract] [Full-text]
6. Ureteral surgery performed by a university gynecologic oncology service.
   Am J Obstet Gynecol, 195(2): 562-6; discussion 566-7. [Abstract] [Full-text]
7. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
   Blood, 108(4): 1165-73. [Abstract] [Full-text]
8. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
   Semin Oncol Nurs, 22(3): 144-51. [Abstract] [Full-text]
9. Skin and wound assessment and care in oncology.
   Semin Oncol Nurs, 22(3): 130-43. [Abstract] [Full-text]
10. Total-body MR-imaging in oncology.
    Eur Radiol, 16(9): 2000-15. [Abstract] [Full-text]
11. Future directions of CAM research in pediatric oncology.
    J Pediatr Oncol Nurs, 23(5): 265-8. [Abstract] [Full-text]
12. Complementary and alternative medicine research initiatives in the Children's Oncology Group and the role of the pediatric oncology nurse.
    J Pediatr Oncol Nurs, 23(5): 261-4. [Abstract] [Full-text]
13. Mind-body therapies for the pediatric oncology patient: matching the right therapy with the right patient.
    J Pediatr Oncol Nurs, 23(5): 254-7. [Abstract] [Full-text]
14. Complementary and alternative medicine in pediatric oncology.
    J Pediatr Oncol Nurs, 23(5): 244-53. [Abstract] [Full-text]
15. Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
    Int J Radiat Oncol Biol Phys, 66(1): 25-30. [Abstract] [Full-text]
16. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Cancer, 107(2): 319-27. [Abstract] [Full-text]
17. Critical review of complementary therapies in haemato-oncology.
    Intern Med J, 36(9): 579-86. [Abstract] [Full-text]
18. Shaping your career to maximize personal satisfaction in the practice of oncology.
    J Clin Oncol, 24(24): 4020-6. [Abstract] [Full-text]
19. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).
    J Clin Oncol, 24(24): 3984-90. [Abstract] [Full-text]
20. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    J Clin Oncol, 24(24): 3871-9. [Abstract] [Full-text]
21. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    J Clin Oncol, 24(24): 3844-51. [Abstract] [Full-text]
22. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    J Clin Oncol, 24(24): 3838-43. [Abstract] [Full-text]
23. Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
    Invest New Drugs, 24(6): 537-42. [Abstract] [Full-text]
24. A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study.
    Invest New Drugs, 24(6): 515-20. [Abstract] [Full-text]
25. Temozolomide: a milestone in neuro-oncology and beyond?
    Expert Rev Anticancer Ther, 6(8): 1187-204. [Abstract] [Full-text]
26. Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Leukemia, 20(9): 1539-41. [Abstract] [Full-text]
27. Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group.
    J Am Coll Surg, 203(3): 269-76. [Abstract] [Full-text]
28. The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894.
    Cancer, 107(3): 489-96. [Abstract] [Full-text]
29. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
    Cancer, 107(3): 599-605. [Abstract] [Full-text]
30. Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America).
    Diagn Microbiol Infect Dis, 56(1): 75-82. [Abstract] [Full-text]
31. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).
    Crit Rev Oncol Hematol, 59(3): 194-204. [Abstract] [Full-text]
32. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.
    Ann Pharmacother, 40(9): 1527-33. [Abstract] [Full-text]
33. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol, 24(25): 4196-201. [Abstract] [Full-text]
34. Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials.
    J Clin Oncol, 24(25): 4177-83. [Abstract] [Full-text]
35. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
    J Clin Oncol, 24(25): 4143-9. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.